本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ADC Therapeutics SA

4.13
-0.1600-3.73%
盘后4.140.0100+0.24%17:54 EDT
成交量:70.96万
成交额:295.57万
市值:4.63亿
市盈率:-2.62
高:4.31
开:4.28
低:4.11
收:4.29
52周最高:4.74
52周最低:1.05
股本:1.12亿
流通股本:9,224.08万
量比:0.59
换手率:0.77%
股息:- -
股息率:- -
每股收益(TTM):-1.5758
每股收益(LYR):-1.6246
净资产收益率:-705.53%
总资产收益率:-22.99%
市净率:-2.32
市盈率(LYR):-2.54

数据加载中...

2022/12/09

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/08

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/14

SEC问询函

CORRESP [Cover] - Correspondence
2022/09/14

SEC问询函

CORRESP [Cover] - Correspondence
2022/06/30

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/17

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/08/03

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/05/06

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/04/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/18

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/03/18

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/18

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/03/11

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/25

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/12

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]